CytoSorbents Corporation is a company that provides critical care therapeutic devices that uses blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The company’s each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.